"Antifungal Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
Descriptor ID |
D000935
|
MeSH Number(s) |
D27.505.954.122.136
|
Concept/Terms |
Antifungal Agents- Antifungal Agents
- Agents, Antifungal
- Therapeutic Fungicides
- Fungicides, Therapeutic
|
Below are MeSH descriptors whose meaning is more general than "Antifungal Agents".
Below are MeSH descriptors whose meaning is more specific than "Antifungal Agents".
This graph shows the total number of publications written about "Antifungal Agents" by people in this website by year, and whether "Antifungal Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 2 | 1 | 3 |
1999 | 4 | 1 | 5 |
2000 | 1 | 1 | 2 |
2001 | 4 | 2 | 6 |
2002 | 11 | 5 | 16 |
2003 | 4 | 0 | 4 |
2004 | 3 | 1 | 4 |
2005 | 1 | 1 | 2 |
2006 | 3 | 1 | 4 |
2007 | 3 | 1 | 4 |
2008 | 1 | 1 | 2 |
2009 | 4 | 2 | 6 |
2010 | 6 | 1 | 7 |
2011 | 7 | 4 | 11 |
2012 | 3 | 1 | 4 |
2013 | 11 | 0 | 11 |
2014 | 3 | 0 | 3 |
2015 | 3 | 2 | 5 |
2016 | 5 | 0 | 5 |
2017 | 3 | 0 | 3 |
2018 | 4 | 2 | 6 |
2019 | 4 | 2 | 6 |
2020 | 1 | 2 | 3 |
2022 | 0 | 3 | 3 |
2023 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antifungal Agents" by people in Profiles.
-
Ajetunmobi OH, Chaturvedi AK, Badali H, Vaccaro A, Najvar L, Wormley FL, Wiederhold NP, Patterson TF, Lopez-Ribot JL. Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation. APMIS. 2023 Nov; 131(11):613-625.
-
Ramage G, Borghi E, Rodrigues CF, Kean R, Williams C, Lopez-Ribot J. Our current clinical understanding of Candida biofilms: where are we two decades on? APMIS. 2023 Nov; 131(11):636-653.
-
Ajetunmobi OH, Wall G, Bonifacio BV, Montelongo-Jauregui D, Lopez-Ribot JL. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening. Methods Mol Biol. 2023; 2658:53-64.
-
Nabeela S, Date A, Ibrahim AS, Uppuluri P. Antifungal activity of alexidine dihydrochloride in a novel diabetic mouse model of dermatophytosis. Front Cell Infect Microbiol. 2022; 12:958497.
-
Sutar Y, Nabeela S, Singh S, Alqarihi A, Solis N, Ghebremariam T, Filler S, Ibrahim AS, Date A, Uppuluri P. Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis. PLoS Biol. 2022 08; 20(8):e3001762.
-
Dahiya R, Dahiya S, Chennupati SV, Davis V, Sahadeo V, Patel JK. Towards the Synthesis of a Heterocyclic Analogue of Natural Cyclooligopeptide with Improved Bio-properties. Curr Org Synth. 2022 03 03; 19(2):267-278.
-
Wall G, Chen E, Hull MV, Lopez-Ribot JL. Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Front Cell Infect Microbiol. 2020; 10:597931.
-
Wall G, Lopez-Ribot JL. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrob Agents Chemother. 2020 08 20; 64(9).
-
Lara HH, Ixtepan-Turrent L, Jose Yacaman M, Lopez-Ribot J. Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles. ACS Appl Mater Interfaces. 2020 May 13; 12(19):21183-21191.
-
Vazquez-Mu?oz R, Arellano-Jimenez MJ, Lopez FD, Lopez-Ribot JL. Protocol optimization for a fast, simple and economical chemical reduction synthesis of antimicrobial silver nanoparticles in non-specialized facilities. BMC Res Notes. 2019 Nov 27; 12(1):773.